Group 1 - The core viewpoint of the articles highlights the performance and valuation of Chao Yan Co., Ltd. in the medical device industry, noting its current stock price and market capitalization [1] - As of May 20, the closing price of Chao Yan Co., Ltd. was 25.65 yuan, with a PE ratio of 69.41, marking a new low in 30 days, and a total market value of 10.987 billion yuan [1] - The average PE ratio for the medical device industry is 49.51, with a median of 36.17, positioning Chao Yan Co., Ltd. at the 98th rank within the industry [1] Group 2 - As of March 31, 2025, Chao Yan Co., Ltd. had 26,755 shareholders, a decrease of 23,411 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] - The main business of Chao Yan Co., Ltd. includes the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products being industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, Chao Yan Co., Ltd. received the second prize of the National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Group 3 - For the first quarter of 2025, Chao Yan Co., Ltd. reported a revenue of 98.4324 million yuan, representing a year-on-year increase of 28.69%, and a net profit of 39.3220 million yuan, reflecting a year-on-year growth of 47.70%, with a sales gross margin of 73.83% [1]
超研股份收盘上涨3.43%，滚动市盈率69.41倍，总市值109.87亿元